PMINYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Picard Medical, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$15.45+2.70 (+21.18%)
Close on Oct 19, 2026
- Market cap
- $28.67M
- P/E (TTM)
- –
- Dividend yield
- –
Picard Medical, Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | % of revenue | YoY |
|---|---|---|---|---|
| Product [Member] | $4.75M | $4.25M | 96.1% | +11.6% |
| Rentals [Member] | $194.00K | $137.00K | 3.9% | +41.6% |
By region
From the segment and revenue-disaggregation notes of Picard Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.